List of bibliographic references indexed by silico
Number of relevant bibliographic references: 23.
[0-20] [
0 - 20][
0 - 23][
20-22][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000333 (2021) |
Arif Ali [Inde] ; Nasim Sepay [Inde] ; Mohd Afzal [Arabie saoudite] ; Nayim Sepay [Inde] ; Abdullah Alarifi [Arabie saoudite] ; M. Shahid [Inde] ; Musheer Ahmad [Inde] | Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19. |
| 000383 (2021) |
Haruna I. Umar [Nigeria] ; Sunday S. Josiah [Nigeria] ; Tolulope P. Saliu [Nigeria] ; Tajudeen O. Jimoh [Thaïlande] ; Adeola Ajayi [Nigeria] ; Jamilu B. Danjuma [Nigeria] | In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants. |
| 000466 (2021) |
Iram Iqbal Hejazi [Inde] ; Md Amjad Beg [Inde] ; Md Ali Imam [Inde] ; Fareeda Athar [Inde] ; Asimul Islam [Inde] | Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease. |
| 000736 (2021) |
Sukanth Kumar Enmozhi [Inde] ; Kavitha Raja [Inde] ; Irudhayasamy Sebastine [Inde] ; Jerrine Joseph [Inde] | Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. |
| 000794 (2021) |
Pawan Kumar Doharey [Inde] ; Vishal Singh [Inde] ; Mallikarjuna Rao Gedda [Inde] ; Amaresh Kumar Sahoo [Inde] ; Pritish Kumar Varadwaj [Inde] ; Bechan Sharma [Inde] | In silico study indicates antimalarials as direct inhibitors of SARS-CoV-2-RNA dependent RNA polymerase. |
| 000795 (2021) |
Serap Yalç N [Turquie] ; Seda Yalç Nkaya [Turquie] ; Fahriye Ercan [Turquie] | In silico detection of inhibitor potential of Passiflora compounds against SARS-Cov-2(Covid-19) main protease by using molecular docking and dynamic analyses. |
| 000983 (2020) |
Mohammed H. Shalayel [Arabie saoudite] ; Ghassab M. Al-Mazaideh [Arabie saoudite] ; Saleem H. Aladaileh [Arabie saoudite] ; Farhan K. Al-Swailmi [Arabie saoudite] ; Mohammad G. Al-Thiabat [Malaisie] | Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15. |
| 000A72 (2020) |
Mohammad Nasir Uddin ; Md Shaharier Amin ; Md Saifur Rahman ; Sonia Khandaker ; Wahhida Shumi ; Md Atiar Rahman ; Sheikh Mahbubur Rahman | Titanium (IV) complexes of some tetra-dentate symmetrical bis-Schiff bases of 1,6-hexanediamine: Synthesis, characterization, and in silico prediction of potential inhibitor against coronavirus (SARS-CoV-2). |
| 000A93 (2020) |
A S Achutha [Inde] ; V L Pushpa [Inde] ; Surendran Suchitra [Inde] | Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors. |
| 000C05 (2020) |
Rashi Srivastava ; Shubham Tripathi ; Sreepoorna Unni ; Arif Hussain ; Shafiul Haque ; Nandita Dasgupta ; Vineeta Singh ; Bhartendu Nath Mishra | Silybin B and Cianidanol Inhibit M pro and Spike Protein of SARS-CoV-2: Evidence from in Silico Molecular Docking Studies. |
| 000C40 (2020) |
Katarina Barali [Serbie] ; Dragica Jorgovanovi [Serbie] ; Katarina Živan Evi [Serbie] ; Evica Antonijevi Miljakovi [Serbie] ; Biljana Antonijevi [Serbie] ; Aleksandra Buha Djordjevic [Serbie] ; Marijana Ur I [Serbie] ; Danijela Uki Osi [Serbie] | Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach. |
| 001070 (2020) |
Satyajit Beura [Inde] ; Prabhakar Chetti [Inde] | In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2. |
| 001073 (2020) |
Helyson Lucas Bezerra Braz [Brésil] ; João Alison De Moraes Silveira [Brésil] ; Aline Diogo Marinho [Brésil] ; Maria Elisabete Amaral De Moraes [Brésil] ; Manoel Odorico De Moraes Filho [Brésil] ; Helena Serra Azul Monteiro [Brésil] ; Roberta Jeane Bezerra Jorge [Brésil] | In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. |
| 001074 (2020) |
Adib Ghaleb [Maroc] ; Adnane Aouidate [Maroc] ; Hicham Ben El Ayouchia [Maroc] ; Mohammed Aarjane [Maroc] ; Hafid Anane [Maroc] ; Salah-Eddine Stiriba [Maroc, Espagne] | In silico molecular investigations of pyridine N-Oxide compounds as potential inhibitors of SARS-CoV-2: 3D QSAR, molecular docking modeling, and ADMET screening. |
| 001075 (2020) |
Sathish Kumar Chidambaram [Inde] ; Daoud Ali [Arabie saoudite] ; Saud Alarifi [Arabie saoudite] ; Surendrakumar Radhakrishnan [Inde] ; Idhayadhulla Akbar [Inde] | In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2. |
| 001076 (2020) |
Rujuta R. Deshpande [Inde] ; Arpita Pandey Tiwari [Inde] ; Narendra Nyayanit [Inde] ; Manisha Modak [Inde] | In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2. |
| 001077 (2020) |
Seref Gul [Turquie] ; Onur Ozcan [Turquie] ; Sinan Asar [Turquie] ; Alper Okyar [Turquie] ; Ibrahim Bar S [Turquie] ; Ibrahim Halil Kavakli [Turquie] | In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials. |
| 001429 (2020) |
Shimaa A. Ahmed [Égypte] ; Doaa A. Abdelrheem [Égypte] ; H R Abd El-Mageed [Égypte] ; Hussein S. Mohamed [Égypte] ; Aziz A. Rahman [Bangladesh] ; Khaled N M. Elsayed [Égypte] ; Sayed A. Ahmed [Égypte] | Destabilizing the structural integrity of COVID-19 by caulerpin and its derivatives along with some antiviral drugs: An in silico approaches for a combination therapy. |
| 001600 (2020) |
Joseph T. Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Beata Jastrzebska [États-Unis] | Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis. |
| 001826 (2020) |
Mahmood Y. Hachim [Émirats arabes unis] ; Ibrahim Y. Hachim ; Kashif Bin Naeem ; Haifa Hannawi ; Issa Al Salmi [Oman] ; Suad Hannawi | C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis. |
| 001921 (2020) |
Abhay Jayprakash Gandhi ; Jalpa Deepak Rupareliya ; V J Shukla ; Shilpa B. Donga ; Rabinarayan Acharya | An Ayurvedic Perspective along with in Silico Study of the Drugs for the Management of Sars-Cov-2. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "silico"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "silico" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= silico
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 |  |
